|Values are valid only on day of printing.|
Detecting drug abuse involving amphetamines, barbiturates, benzodiazepines, cocaine, opiates, phencyclidine, tetrahydrocannabinol, and methadone
This test is intended to be used in a setting where the test results can be used to make a definitive diagnosis
Testing begins with screening tests for drugs of abuse. Positives are confirmed and quantitated by definitive methods. Gas chromatography-mass spectrometry for amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, phencyclidine, and tetrahydrocannabinol metabolite at additional charge. Methadone and opiates that screen positive will be quantified with liquid chromatography-tandem mass spectrometry at an additional charge.
See Adulterant Survey Algorithm in Special Instructions.
This test uses immunologic testing for drugs by class and screens for the presence of amphetamines, barbiturates, benzodiazepines, cocaine metabolite, methadone, opiates, phencyclidine, and tetrahydrocannabinol in urine. Positive immunologic results are confirmed by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry.
The specific drug identified will be reported.
Enzyme-multiplied immunoassay technique cutoff concentrations:
Amphetamines: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 200 ng/mL
Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL
Methadone: 300 ng/mL
Opiates: 300 ng/mL
Phencyclidine: 25 ng/mL
Tetrahydrocannabinol carboxylic acid: 50 ng/mL
Results of this test are confirmed and should be considered definitive.
A positive result indicates that the patient has used the drugs detected in the recent past.
For information about drug testing, including estimated detection times, see Drugs of Abuse Testing at http://www.mayomedicallaboratories.com/articles/drug-book/index.html
Creatinine and specific gravity are measured as indicators of specimen dilution.
Not intended for use in employment-related testing.
The test does not screen for drug classes other than those listed above. More comprehensive screening is available using the serum or urine drug screens (CDAS / Drug Screen, Prescription/OTC, Serum or CDAUN / Drug Screen, Prescription/OTC, Urine).
Porter WF, Moyer TP: Clinical toxicology. In Tietz Textbook of Clinical Chemistry. Fourth edition. Edited by CA Burtis, ER Ashwood. Philadelphia, WB Saunders Company, 1993, pp 1155-1235